These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 4721804)

  • 21. [Clinical use of capromycin in pulmonary tuberculosis].
    Zierski M; Bek E
    Gruzlica; 1969 Jul; 37(7):649-57. PubMed ID: 4900503
    [No Abstract]   [Full Text] [Related]  

  • 22. [Role of pneumonectomy in the complex therapy of patients with pulmonary tuberculosis, coniotuberculosis with side effects of antibacterial preparations].
    Puk'ianenko MS
    Probl Tuberk; 1974; (9):47-51. PubMed ID: 4410809
    [No Abstract]   [Full Text] [Related]  

  • 23. [Lung resection in patients with tuberculosis, demonstrating symptoms of antitubercular drug hypersensitivity].
    Akmatov TA
    Sov Zdravookhr Kirg; 1972; 6():43-6. PubMed ID: 4666880
    [No Abstract]   [Full Text] [Related]  

  • 24. [Biophysical methods of diagnosis of drug allergy in patients with pulmonary tuberculosis].
    Shutskaia EI; Kamenskaia VV; Kashafutdinova ZN; Kolpakova TA; Zelinskiĭ IuG
    Probl Tuberk; 1982 Apr; (4):63-6. PubMed ID: 7088944
    [No Abstract]   [Full Text] [Related]  

  • 25. [Indications and contraindications for infusion of antibacterial drugs into pulmonary arteries in tuberculosis].
    Nizhnikov GI
    Probl Tuberk; 1976 Apr; (4):32-5. PubMed ID: 981213
    [No Abstract]   [Full Text] [Related]  

  • 26. [Studies on modern treatment of pulmonary tuberculosis complicated by diabetes mellitus].
    Górecki R; Zieliński C
    Gruzlica; 1967 Feb; 35(2):127-32. PubMed ID: 6045022
    [No Abstract]   [Full Text] [Related]  

  • 27. [Reactions of pulmonary tissue and sequelae occurring in the lungs in the course of treatment of chronic tuberculosis. I. Pulmonary fibrosis].
    Szymańska D
    Gruzlica; 1973 Feb; 41(2):145-50. PubMed ID: 4695785
    [No Abstract]   [Full Text] [Related]  

  • 28. Evaluation of capreomycin and ethambutol in retreatment of pulmonary tuberculosis.
    Lester W; Fischer DA; Dye WE
    Ann N Y Acad Sci; 1966 Apr; 135(2):890-903. PubMed ID: 5220244
    [No Abstract]   [Full Text] [Related]  

  • 29. [Comparison of combination therapy of Capreomycin, ethionamide and cycloserin with that of kanamycin, ethionamide and cycloserin for the retreatment of pulmonary tuberculosis].
    Kitamoto O; Oka S; Kawamori Y; Gomi J; Sugiyama K
    Saishin Igaku; 1970 Jul; 25(7):1546-55. PubMed ID: 5451178
    [No Abstract]   [Full Text] [Related]  

  • 30. [Functional state of the liver in patients with pulmonary tuberculosis during treatment with chemopreparations of the 2d series].
    Vasilik GV
    Probl Tuberk; 1968; 46(8):43-7. PubMed ID: 5709113
    [No Abstract]   [Full Text] [Related]  

  • 31. [Enzymatic parameters of the liver function in patients with active pulmonary tuberculosis and adverse reactions to chemotherapeutic drugs].
    Bondarenko VP
    Probl Tuberk; 1979 Nov; (11):37-40. PubMed ID: 530967
    [No Abstract]   [Full Text] [Related]  

  • 32. [Capreomycin. Therapeutic trial with patients with advanced chronic polyresistant pulmonary tuberculosis].
    Rey JC; González Montaner LJ; Cetrángolo A; Iannello JA
    Prensa Med Argent; 1967 Jun; 54(16):731-5. PubMed ID: 5614108
    [No Abstract]   [Full Text] [Related]  

  • 33. [Blood concentrations and anti-bacterial potency of the blood in relation to secondary antitubercular agents].
    Soejima R; Kaku R; Nagao T; Nozute H
    Saishin Igaku; 1966 Jan; 21(1):62-7. PubMed ID: 5965947
    [No Abstract]   [Full Text] [Related]  

  • 34. [Comparison of the retreatment cases of pulmonary tuberculosis].
    Sasaki Y
    Kekkaku; 2009 Dec; 84(12):777-8. PubMed ID: 20196274
    [No Abstract]   [Full Text] [Related]  

  • 35. [Development of agranulocytosis in long-term treatment of tuberculosis with Ethoxyd in combination with other antitubercular agents].
    Gol'dberg AS; Medved' RI
    Klin Med (Mosk); 1970 Dec; 48(12):43-7. PubMed ID: 5518596
    [No Abstract]   [Full Text] [Related]  

  • 36. [Research on primary resistance to antitubercular agents and antibiotics in the antituberculosis centers].
    Santi GM; Poggiopollini M
    Minerva Med; 1967 Jun; 58(49):2285-8. PubMed ID: 6029301
    [No Abstract]   [Full Text] [Related]  

  • 37. [Logistic analysis on risk factors related to smear positive pulmonary tuberculosis].
    Li XT; Ye LX; Shi LY; Xiao AQ; Hou SY; Wang W; Ye JJ; Tang SW; Zhao HH; Xu HT
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Aug; 25(8):658-60. PubMed ID: 15555385
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rifampicin and ethambutol in the treatment of drug resistant and far advanced pulmonary tuberculosis (with a note on capreomycin).
    Pines A; Raafat H; Siddiqui GM
    J Ir Med Assoc; 1970 Mar; 63(393):82-5. PubMed ID: 4984340
    [No Abstract]   [Full Text] [Related]  

  • 39. [Microcirculatory changes during the chemotherapy of pulmonary tuberculosis].
    Poletaev SD; Struzhko IB
    Probl Tuberk; 1985; (4):17-22. PubMed ID: 4001103
    [No Abstract]   [Full Text] [Related]  

  • 40. [Association of tuberculosis with syphilis].
    D'iakonov MF; Lishchinskiĭ BD; Kuznetsova EN; Podlesnaia AK
    Probl Tuberk; 1975; (5):84-5. PubMed ID: 1144354
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.